Kenneth Conrad Jackson, II, Pharm - Larkin University
Curriculum Vitae
Kenneth Conrad Jackson, II
|Work: |Home: |
|Larkin Health Sciences Institute |625 Winter Wren Lane |
|College of Pharmacy |Blythewood, South Carolina 29016 |
|18301 N. Miami Avenue, Suite 1 |(503) 840-4098 Cell |
|Miami, Florida 33169 |kenneth.c.jackson.2@ |
|(305) 760-7500 x 7510 | |
|kjackson@ | |
EDUCATION
1994 – 1996 Doctor of Pharmacy (Cum Laude), Creighton University School of Pharmacy and Allied Health Professions; Conferred December 1996.
1984 – 1989 Bachelor of Science in Pharmacy, University of Houston College of Pharmacy; Conferred May 1989.
FELLOWSHIP
2009 – 2010 Academic Leadership Fellow, the American Association of Colleges of Pharmacy.
1998 – 1999 Pain Management and Palliative Care Research Fellow, University of Utah College of Pharmacy and Pain Management Center.
Research focus: evidence-based pharmaceutical care in chronic pain and palliative care patient populations.
RESIDENCY
1997 – 1998 Nutritional Support Resident, St. Mary of the Plains Hospital – Lubbock, Texas. ASHP accredited residency in Nutritional Support Pharmacy Practice.
Rotations included: Burn/Trauma, Clinician Dietetics, Dialysis, DUE, Home Infusion, Neonatal Nutritional Support, Adult Nutritional Support, Anticoagulation Clinic, and Pharmacy Administration.
ACADEMIC APPOINTMENTS
2015 – Present College of Pharmacy, Larkin Health Sciences Institute – Miami, Florida
Professor and Chair (Founding)
2013 – 2015 School of Pharmacy, Levine College of Health Sciences, Wingate University – Hendersonville and Wingate, North Carolina
Professor (2013 – )
Courses:
Pharmacotherapy for Pain, Course Coordinator and Primary Faculty Member
10 Spring 2014 – 11 hours
Problem Based Learning
12 Spring 2014 – Course Facilitator and Case Author
13 Fall 2014 – Course Facilitator
14 Spring 2015 – Case Author
Pharmacy Ethics and Law
16 Fall 2014 (8 hours)
17 Controlled Substances – 4 hours
18 Refusal to Provide Care – 2 hours
19 Legal Issues with Substance Abuse – 2 hours
2012 – 2013 School of Pharmacy, University of Charleston – Charleston, West Virginia
Professor (2012 – 2013) & Chair (2012 – 2013) Department of Pharmacy Practice
Maier Foundation Chair in Pharmacy (2012 – 2013)
Courses:
Interdisciplinary Case Conference – Pain Management
27 Collaborative conference with the West Virginia School of Osteopathic Medicine. (4th year pharmacy and medical students)
PHAR 719 Pharmacotherapy II, Team Member Fall 2012
29 Pain Management – 3 hours
30 Substance Use Disorders – 3 hours
31 Pain and Palliative Care – 2 hours
32 Case: Pain and Depression – 2 hours
PHAR 740 Pharmacotherapy III, Team Member Spring 2013
34 Substance Abuse and Infectious Complications – 2 hours
35 Oncology Overview and Antineoplastic Agents – 5 hours
36 Leukemia and Lymphoma – 1 hour
37 Palliative Care – 4 hours
2011 – 2012 School of Pharmacy, South University – Columbia, South Carolina
Professor (2011 – 2012)
Campus Dean – Columbia, South Carolina (2011 – 2012)
Courses:
PHA 3114 Pathophysiology II, Facilitator Columbia Campus Quarter 2 Fall 2011.
Leadership Elective. Quarter 2 Fall 2011.
47 2 hour lecture Personal Leadership
Integrated Sequence VIII – Neurology. Quarter 7 Spring 2012
49 3 hour lecture Opioid Pharmacotherapy
50 3 hour integrated case pain and mood disorders
2007 – 2011 School of Pharmacy, Pacific University – Hillsboro, Oregon
Associate Professor - Tenure Track (2007 – 2010)
Associate Professor – with Tenure (2010 –2011)
Professor – with Tenure (2011)
Assistant Dean for Program Development (2008 - 2010)
Associate Dean (2010 –2011)
Courses:
59 PHRM 644 Neuro-Psych II, Founding Module Coordinator and Team Member Fall 2010, Fall 2011
60 College of Health Professions Interdisciplinary Case Conference - Palliative Care. Lead Team Member Spring 2010
61 PHRM 618 Pain Management, Founding Module Coordinator and Team Member Fall 2008, Fall 2009
62 PHRM 602 Management of Patient Care, Team Member Fall 2007, Fall 2008
63 PHRM 611 Pharmacotherapy and Disease State Management: Oncology – Founding Module Coordinator and Team Member Spring 2008, Team Member Spring 2009, Spring 2011
64 PHRM 612 Pharmacotherapy and Disease State Management: Neurology – Founding Module Coordinator and Team Member Spring 2008
65 PHRM 613 Pharmacotherapy and Disease State Management: Psychiatry – Founding Module Coordinator and Team Member Spring 2008
66 PHRM 670 Chronic Pain and Palliative Care Elective – Founding Module Coordinator and Team Member Spring 2008
67 PHRM 606 Pharmacotherapy and Disease State Management: Clinical Immunology –Team Member Fall 2007
68 PHRM 608 Pharmacotherapy and Disease State Management: Gastrointestinal and Hepatic –Team Member Spring 2008
69 PHRM 614 Pharmacotherapy and Disease State Management: Clinical Nutrition –Team Member Spring 2008
70 PHRM 706Academic Pharmacy Clerkship: Founding Preceptor, Summer 2008.
2004 – 2007 College of Pharmacy, University of Utah – Salt Lake City, Utah
Clinical Associate Professor of Pharmacotherapy (Core Faculty)
Department of Pharmacotherapy and Pharmacotherapy Outcomes Research Center
Courses:
76 Pain Management Pharmacotherapy Clerkship – Preceptor Fall 2004, Spring 2005, Fall 2005, Spring 2006
77 Interdisciplinary Palliative Care Clerkship – Preceptor Summer 2006, Fall 2006, Spring 2007
78 Pain and Palliative Care Residency Rotation – Preceptor Spring 2005, Fall 2005, Spring 2006
79 Neurosensory Module: Pain and Palliative Care Lectures – Team Member Fall 2005, 2006
80 Interdisciplinary Palliative Care Elective – Team Leader Spring 2006 (New Course), Spring 2007
81 PharmD Seminar – Section Coordinator Fall 2006, Spring 2007
82 Physician Assistant Studies - Pain and Palliative Pharmacotherapy Lectures Spring 2006, 2007
2000 – 2004 School of Pharmacy, Texas Tech University Health Sciences Center – Lubbock, Texas
Assistant Professor (Tenure-track)
Courses:
87 Advanced Pain Management – Team Member/Leader – Fall 2002 (New Course), 2003, 2004
88 Neurosensory Pharmacotherapy – Team Member Fall 2002, 2003
89 Clinical Research and Literature Evaluation – Team Member – Spring 2001, Spring 2002, Spring 2003
90 Pharmaceutical Care I – Team Member – Spring 2001, Spring 2002, Guest Lecturer Spring 2003
91 Case Studies III – Team Member and Lubbock Campus Coordinator – Spring 2001
92 Pharmacotherapy Grand Rounds – Team Member and Campus Coordinator – Fall 2001, Fall 2002, Spring 2004, Fall 2004
93 Ambulatory Clinical Skills – Preceptor Spring 2001, Fall 2001, Spring 2002
94 Pharmacotherapy XIV: Oncology – Guest Lecturer – Spring 2001, Spring 2002, Spring 2003, Spring 2004
95 Journal Club and Lifelong Learning – Team Member – Fall 2000
96 TxPharm: Neurology – Team Member – Summer 2001, Summer 2002, Fall 2002
97 Pain Management Pharmacotherapy Clerkship – Preceptor – Spring 2001, Fall 2001, Spring 2002, Spring 2003, Spring 2004
98 Pain Management Residency Rotations – Preceptor – Spring 2001, Fall 2002
2001 – 2004 Pain Management Fellowship and Residency Programs, International Pain Institute at Texas Tech Medical Center – Lubbock, Texas.
Adjunct Clinical Faculty
Lectures: NSAID use in Chronic Pain, Tricyclic Antidepressants in Neuropathic Pain, Anticonvulsants in Neuropathic Pain, Appropriate Use of Skeletal Muscle Relaxants, Methadone: Pharmacology and Pharmacokinetics Issues, Opioid Pharmacotherapy, Time-Contingent Approach to Pain Pharmacotherapy, Pharmacodynamics and Pharmacokinetics in Pain Medicine, Substance Abuse in Pain Management Populations, Opioid Use in Terminal Disease, Neuropsychiatric Complications of Terminal Disease.
2001 Creighton University School of Pharmacy and Allied Health Professions – Omaha, Nebraska.
Adjunct Clinical Faculty - Nontraditional Doctor of Pharmacy Program.
Preceptor: Pain Management Pharmacotherapy Clerkship Spring 2001
2000 University of Arkansas for Medical Sciences College of Pharmacy – Little Rock, Arkansas.
Adjunct Clinical Faculty - Nontraditional Doctor of Pharmacy Program.
Preceptor: Pain Management Pharmacotherapy Clerkship Fall 2000
1999 – 2000 University of Mississippi School of Pharmacy – Jackson, Mississippi.
Clinical Assistant Professor (Adjunct faculty)
Preceptor: Inpatient general medicine clerkship Fall 1999, Spring 2000
1998 – 1999 College of Pharmacy, University of Utah – Salt Lake City, Utah.
Clinical Instructor
Courses:
119 Pain Management – Fall 1998
120 Palliative/hospice care – Spring 1999
121 Pain Management Pharmacotherapy Clerkship – Fall 1998, Spring 1999
122 Pain Management Pharmacy Residency Rotation – Fall 1998, Spring 1999
PROFESSIONAL AFFILIATIONS
2009 – 2011 Clinical Consultant, Palliative Care Consulting Group – Dublin, Ohio.
2005 – 2007 Clinical Consultant, HospiScript Services LLC – Montgomery, Alabama.
2006 – 2007 Clinical Pharmacy Specialist, University Hospital Palliative Care Interdisciplinary Consult Service. University of Utah Health Sciences Center - Salt Lake City, Utah.
2005 – 2007 Researcher, Pharmacotherapy Outcomes Research Center at the University of Utah College of Pharmacy – Salt Lake City, Utah.
2004 – 2007 Clinical Pharmacy Specialist, University Pain Management Center. University of Utah Health Sciences Center – Salt Lake City, Utah.
2001 – 2004 Clinical Pharmacy Consultant, Hospice of Lubbock – Lubbock, Texas. Provide clinical pharmacy consultative services.
2000 – 2004 Credentialed Pharmacist with Clinical Privileges:
University Medical Center – Lubbock, Texas.
2000 – 2004 Clinical Pharmacy Specialist, International Pain Institute at Texas Tech Medical Center – Lubbock, Texas.
Provide specialized clinical pharmacotherapy consultations. Provide medical education to attending physicians and pain management fellows.
1999 – 2000 Manager – Clinical Pharmacy Services, St. Dominic – Jackson Memorial Hospital.
Managed all aspects of clinical pharmacy services.
1998 – 1999 Clinical Pharmacy Consultant (Volunteer), Vista Care Hospice – Salt Lake City, Utah.
Weekly rounds; staff/physician education; on-call for pharmacotherapy consults.
1995 – 1996 Staff Pharmacist, Columbia Medical Center West – El Paso, Texas. Interpretation of physicians’ orders, monitoring of patient profiles, provision of drug information to hospital staff and physicians, participation on code blue team, pharmacokinetic dosage adjustment.
1994 – 1995 Staff Pharmacist, Providence Memorial Hospital – El Paso, Texas. Interpretation of physicians’ orders, monitoring of patient profiles, provision of drug information to hospital staff and physicians, participation on code blue team.
1993 – 1994 Pharmacy Director, NMC Homecare – El Paso, Texas.
Provided comprehensive pharmacy services to home infusion and clinic patients. Therapies dealt with included: IDPN, TPN, chemotherapy, I.V. antibiotics, and pain management.
1993 – 1993 Staff Pharmacist, Sierra Medical Center – El Paso, Texas.
Interpretation of physicians’ orders, provision of drug information to hospital staff and physicians, member of the nutrition support committee.
1991 – 1993 Pharmacy/Operations Manager, The I.V. Clinic – Houston Texas. Provided comprehensive pharmacy services to home infusion therapy patients. Responsible for all aspects of pharmaceutical care of patients, and materials management of facility. Facility was a start up operation, received JCAHO certification Fall 1992. Therapies dealt with included: IVIG, factors eight and nine, TPN, pain management, chemotherapy, I.V. Antibiotics.
1989 – 1991 Staff Pharmacist, Randall’s Pharmacy – Houston, Texas.
Patient counseling, interpretation of prescriptions, patient monitoring, OTC medication information and selection, inventory control.
REGISTRATION
1989 – Present Texas State Board of Pharmacy R.Ph. license 31225.
2014 – 2015 North Carolina Board of Pharmacy R.Ph. license 24024.
2009 – 2012 Oregon Board of Pharmacy R.Ph. license 0011745 (Inactive).
1998 – 2008 Utah Division of Occupational and Professional Licensing R.Ph. License
363584-1701 (Inactive).
1999 – 2001 Mississippi Board of Pharmacy R.Ph. License T09256 (Inactive); Controlled Substance License CS-T09256 (Inactive).
1996 – 2000 Alabama State Board of Pharmacy R.Ph. license 13259 (Inactive).
CERTIFICATION
2014 - Certified Pain Educator – Recertified, March 18, 2014; American Society of Pain Educators.
2009 - 2014 Certified Pain Educator – Certificate #125, Awarded March 26, 2009; American Society of Pain Educators.
1992 University of Houston College of Pharmacy – Aseptic Techniques for Home Care. October 1992.
PUBLISHED ABSTRACTS (*denotes peer review)
1. *Jackson KC, Lipman AG. The Development and Implementation of Evidence-based Medicine in Palliative Care. (abstract) Journal of Palliative Medicine, Summer 1999 2(2):247.
2. *Jackson KC, Lipman AG. Evidence-based, Drug Therapy Symptom Control Guidelines for Palliative Care. (abstract) Journal of Palliative Medicine, Summer 1999 2 (2):283.
3. *Jackson KC. Legal and Professional Issues of Using Opioids in Chronic Non-Malignant Pain (abstract) International Pharmaceutical Abstracts November 15, 1999.
4. *Jackson KC. Non-Malignant pain and Opioids: Introduction to a Complex Issue. (abstract) International Pharmaceutical Abstracts November 15, 1999.
5. *Jackson KC, Raehl CL, Bond CA. Readability of Over the Counter Analgesics. Pharmacotherapy 22(3): 408, 2002.
6. *Jackson KC, Riney DH. Pain assessment and pharmacotherapy in terminal disease: attitudes, knowledge, and practices of hospice nurses. Pharmacotherapy 22(10): 1326, 2002.
7. *Tsikouris JP, Cox CD, Jackson KC, Diaz JA, Seifert CF. Thrombolytic Fibrin Specificity Influences Activated Partial Thromboplastin Time Prolongation In Vitro. Journal of the American College of Cardiology 39: 331A, 2002.
8. *Tsikouris JP, Cox CD, Jackson KC, Diaz JA, Seifert CF. Thrombolytic Fibrin Specificity Influences Activated Partial Thromboplastin Time Prolongation In Vitro. Pharmacotherapy 22: 407 (19E), 2002.
9. *Herndon CM, Jackson KC, Fike D, Woods T. End-of-Life care education in United States pharmacy schools. Pharmacotherapy 23(3):396, 2003.
10. *Jackson KC. Evaluation of Skeletal Muscle Relaxant Use for Acute Musculoskeletal Pain and Injury in Ambulatory Care. The Journal of Pain 4(2 Suppl 1):84 (934), 2003.
11. *Jackson KC, Wiffen PJ. Systematic review of codeine in the treatment of cancer pain. The Journal of Pain 5(3 Suppl 1): 49 (761), 2004.
*Lipman AG, Jackson KC, Stockdale W, Oderda GM. The Treatment Outcomes of Pain Survey (TOPS): A Validated Health Related Quality of Life (HRQoL) Outcomes Instrument for Research and Practice. 11th World Congress on Pain. International Association for the Study of Pain. August 2005 Sydney, Australia.
*Jackson KC, Lipman AG, Oberg BE, Oderda GM. Health related quality of life for chronic pain patients: A two year analysis of the treatment outcomes of pain survey (TOPS) Journal of Pain 7(4 Suppl 1): 84, 2006.
12. *Jackson KC, Brixner DI, Oderda GM, Oberg B, Sheng X. Compliance and persistence of fixed dose versus free dose combination therapy with valsartan and HCTZ for patients with hypertension. Value in Health 9(6): A363, 2006. (Presented in Copenhagen, Denmark)
13. *Brixner DI, Jackson KC, Sheng X, Biskupiak J, Keskinaslan A. Compliance with Multiple Combination Antihypertensive Pharmacotherapy in a Large US Database. Value in Health 10(6):A431, 2007. (Presented in Dublin, Ireland)
14. *Jackson KC, Brixner DI, Oderda G, Oberg B, Sheng X, Keskinaslan A. Compliance and Economic Outcomes with Valsartan and HCTZ Combination Therapy for Hypertensive Patients. The Journal of Clinical Hypertension 9(5 Suppl 4):A1-226, 2007.
15. *Buhler AV, Arendt CS, Elbarbry F, Fortner J, Harrelson JP, Jackson KC, Jordan JM. Cross-Discipline Case Studies Integrate Basic Science and Clinical Skills for First-Year Students in Modified-Block Curriculum. American Journal of Pharmaceutical Education 73(4): Article 57 page 4, 2009.
16. *Jackson KC, Cawley PA, Buhler AV. Development and Implementation of an Early Pain Management Course within a Modified Block Curriculum. American Journal of Pharmaceutical Education 73(4): Article 57 page 71, 2009.
17. *Jordan JM, Vo T, Cawley PA, Flynn D, Fortner J, Fujisaki BS, Jackson KC, Marcus K. End of Year Bootcamp: A Comprehensive Assessment of Students' Competencies and Readiness for APPE. American Journal of Pharmaceutical Education 73(4): Article 57 page 73, 2009.
18. *Fortner J, Stein SM, Jackson KC, Millard ME. Reinforcing Chemotherapy Sterile Preparation Techniques. American Journal of Pharmaceutical Education 73(4): Article 57 page 86, 2009.
19. *Karimi R, Bonnarens JB, Jackson KC, Stein SM. Promoting Faculty Enrichment in a Learner-Centered PharmD Program. American Journal of Pharmaceutical Education 74 (5) Article 96, page 142, 2010.
20. *Brown SE, Jackson KC, Christensen LM. Development and Implementation of a Regional Collaboration for Advanced Pharmacy Practice Experiential Education. American Journal of Pharmaceutical Education 74 (5) Article 96, page 29, 2010.
21. *Jackson KC, Christensen LM, Barton R. Implementation of a Health System Tracking Approach to Assignment of Advanced Pharmacy Practice Experiences. American Journal of Pharmaceutical Education 74 (5) Article 96, page 34, 2010.
22. *Cawley PA. Jackson KC. Pain Passport: A Methodology for Assessing Competency in Pain Pharmacotherapy. American Journal of Pharmaceutical Education 74 (5) Article 96, page 103, 2010.
23. *Jackson KC, Fujisaki BS, Shipman N. Development and implementation of a post-doctoral academic fellowship. American Journal of Pharmacy Education 75(5) Article 105, page 81, 2011.
24. *Karimi R, Jackson KC, Stein SM. Building a coherent curricular interface in a learner-centered paradigm. American Journal of Pharmacy Education 75(5) Article 105, page 129, 2011.
PUBLISHED JOURNAL ARTICLES (*denotes peer review)
1. *Frankel EH, Enow NB, Jackson KC, et al. Methods of Restoring Patency to Occluded Feeding Tubes. Nutrition in Clinical Practice 13:129-131, June 1998.
2. *Jackson KC. Spinal Opioids in Chronic Pain. Infusion 5(9):59-63, June 1999.
3. *Jackson KC. Anxiety in Palliative Care Patients. Journal of Pharmaceutical Care in Pain and Symptom Control 7(4):23-35, 2000.
4. *Jackson KC. Delirium in Palliative Care Patients. Journal of Pharmaceutical Care in Pain and Symptom Control 7(4):59-70, 2000.
5. *Martin AC, Jackson KC. Depression in Palliative Care Patients. Journal of Pharmaceutical Care in Pain and Symptom Control 7(4): 71-89, 2000.
6. Jackson KC. Are Opioids Indicated in Chronic Non-Malignant Pain? A Clinical Dilemma. Advance for Directors in Rehabilitation 8(1): 25-6, January 1999.
7. *Jackson KC, Chambers MS. Oral Mucosal Problems in Palliative Care Patients. Journal of Pharmaceutical Care in Pain and Symptom Control 8(1):143-161, 2000.
8. *Jackson KC. Nutrition and Hydration Problems in Palliative Care Patients. Journal of Pharmaceutical Care in Pain and Symptom Control 8(1):183-197, 2000.
9. *Jackson KC, Wellman M. Evidence-based Review of the Management of Mucositis. Journal of Pharmaceutical Care in Pain and Symptom Control 8(3):5-21, 2000.
10. *Jackson KC. Leadership Summits on Pain Management: New Standards Expectations for Pain Assessment and Treatment. Journal of Pharmaceutical Care in Pain and Symptom Control 8(4):57-59, 2000.
11. *Herndon CM, Jackson KC, Hallin P. Pharmacotherapy in Palliative Care: Management of Opioid-Induced Gastrointestinal Effects. Pharmacotherapy 22(2): 240-250, 2002.
12. *Kuritzky L, Barnett R, Doan H, Eli B, Genato EC, Jackson KC, Jones T, Miller J, Pettine K, Rashbaum R, Uppal S, Weil AJ, Zuckerman J. The 10-minute examination for low back pain: An efficient and effective approach to diagnosis and management. The Journal of Musculoskeletal Medicine 9:497-505, 2002.
13. *Tsikouris JP, Jackson KC, Fike DS, et al. Thrombolytic fibrin specificity influences activated partial thromboplastin time prolongation in vitro. Blood Coagulation and Fibrinolysis 13:725-731, 2002.
14. *Jackson KC, St. Onge EL. Antidepressant pharmacotherapy: considerations for the pain clinician. Pain Practice 3(2):135-143, 2003.
15. *Herndon CM, Kalauokalani DAK, Cunningham AJ, Jackson KC, Dunteman ED. Anticipating and treating opioid-associated adverse effects. Expert Opin Drug Saf 2(3):305-319, 2003.
16. *Herndon CM, Jackson K 2nd, Fike DS, Woods T. End-of-life care education in United States pharmacy schools Am J Hosp Palliat Care. 2003 Sep-Oct;20(5):340-4.
17. *Jackson KC 2nd, Mannes A. Persistent pain management for improved quality of life. J Am Pharm Assoc (Wash DC). 2003 Sep-Oct;43(5 Suppl 1):S30-1.
18. *Jackson KC, Lipman AG. Pharmacotherapy for Anxiety in Palliative Care. Cochrane Database Syst Rev. 2004;(1):CD004596.
19. *Jackson KC, Stanford BL. Opioid Pharmacotherapy in Terminal Disease. Pain Practice 4(1): 30-38, 2004.
20. *Jackson KC, Lipman AG. Drug Therapy for Delirium in Palliative Care. Cochrane Database Syst Rev. 2004;(2):CD004770.
21. * Grahmann PH, Jackson KC, Lipman AG. Clinician beliefs about opioid use and barriers in chronic nonmalignant pain. J Pain Palliat Care Pharmacother. 2004;18(2):7-28.
22. *Jackson KC. Low Back Pain Pharmacotherapy. Drugs Today (Barc). 2004; 40(9):765-72.
23. *Jackson KC, Wohlt P, Fine PF. Dexmedetomidine: A novel agent with palliative medicine potential. J Pain Palliat Care Pharmacother. 2006;20(2):23-7.
24. *Asche C, Seal B, Jackson KC, Oderda GM. Economic evaluations in pain management: Principles and Methods. J Pain Palliat Care Pharmacother. 2006, 20(3): 15-23.
25. *Jackson KC. Pharmacists’ perspectives on pain and palliative care. J Pain Palliat Care Pharmacother. 2006, 20(3): 37-8.
26. *Jackson KC. Pharmacotherapy for Neuropathic Pain. Pain Practice 2006, 6 (1), 27-33.
27. *Neyens R, Jackson KC. Novel Opioid Antagonists for Opioid-Induced Bowel Dysfunction and Postoperative Ileus. J Pain Palliat Care Pharmacother. 2007, 21(2): 27-33.
28. *Jackson KC, Nahoopii R, Dirani R, Brixner D. An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation. J Occup Environ Med. 2007 Apr;49(4):453-60.
29. *LaFleur J, Said Q, McAdam-Marx C, Jackson K, Mortavazi M. Problems in Studying the Association Between Race and Pain in Outcomes Research. J Pain Palliat Care Pharmacother. 2007, 21(3): 57 – 62.
30. *Jackson K, Wiffen P. Codeine, alone and with paracetamol (acetaminophen), for cancer pain. (Protocol) Cochrane Database of Systematic Reviews 2007, Issue 3.
31. *Oderda GM, Said Q, Evans RS, Stoddard JG, Loyd J, Jackson KC, et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother. 2007 Mar;41(3):400-6.
32. *Hadjistavropoulos T, Herr K. Turk D, Fine P, Dworkin R, Helme R, Jackson K, et al. An Interdisciplinary Expert Consensus Statement on Assessment of Pain in Older Persons. Clin J Pain. 2007 Jan;23(1 Suppl):S1-43.
33. *Shih A, Jackson KC. The Role of Corticosteroids in Palliative Care. J Pain Palliat Care Pharmacother. 2007, 21(4):69-76.
34. * Brixner DI, Jackson KC, Sheng X, Nelson RE, Keskinaslan A. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations. Curr Med Res Opin. 2008 Sep;24(9):2597-607.
35. *Jackson KC, Sheng X, Nelson RE, Keskinaslan A, Brixner DI. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Clin Ther. 2008 Aug;30(8):1558-63.
36. *Fine PG, Portenoy RK, Chou R, Cruciani RA, Gordon D, Inturrisi CE, Jackson K, Moskowitz M, Pasternak G, Raja S, Webster L, Zhukovsky DS. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage 2009; 38(3):418-25.
37. *Strassels S, McNicol ED, Francia MBD, Pepin J, Jackson KC. Meperidine (pethidine) for treatment of postoperative pain in adults (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD007509.
38. *Schneider EF, Jones MC, Farris KB, Havrda D, Jackson KC, Hamrick TS. Faculty perceptions of appropriate faculty behaviors in social interactions with student pharmacists. Am J Pharm Educ 2011; 75(4): Article 70.
39. *Candy B, Jackson KC, Jones L, TookmanA, King M. Drug therapy for symptoms associated with anxiety in adult palliative care patients. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD004596.
40. *Candy B, Jackson KC, Jones L, Leurent B, Tookman A, King M. Drug therapy for delirium in terminally ill adult patients. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No. CD004770.
41. *Schremmer C, Derry S, Jackson KC, Wiffen PJ, Bell RF, Strassels S, Straube S. Codeine, alone and with paracetamol (acetaminophen), for cancer pain (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD006601.
42. *Tillery E, Rubingh C, Hanson J, Jackson II KC. Medical Marijuana for the Management of Chronic Pain: Issues for Consideration. Austin J Pharmacol Ther. 2014; 2(1): 4.
43. *Straube C, Derry S, Jackson KC, Wiffen PJ, Bell RF, Strassels S, Straube S. Codeine, alone and with paracetamol (acetaminophen), for cancer pain. Cochrane Database of Systematic Reviews 2014, Issue 9. Art. No.: CD006601.
44. *Kral L, Jackson KC, Uritsky T. A practical guide to tapering opioids. Mental Health Clinician, In press. Accepted December 2014.
PUBLISHED CLINICAL PRACTICE GUIDELINES (*denotes peer review)
1. *Burckhardt CS, Goldenberg D, Crofford L, Gerwin R, Gowans S, Jackson K, Kugel P, McCarberg W, Rudin N, Schanberg L, Taylor AG, Taylor J, and Turk D. (2005). Guideline for the Management of Fibromyalgia Syndrome Pain in Adults and Children, APS Clinical Practice Guideline Series, No. 4 Glenview, IL: American Pain Society.
PUBLISHED BOOKS (*denotes peer review)
1. *Evidence-based Symptom Control in Palliative Care: Systematic Reviews and Validated Clinical Practice Guidelines for 15 Common Problems in Patients with Life-limiting Disease. Haworth Press. Editors: Lipman AG, Jackson KC, Tyler LS. Publication: September, 2000.
2. *Breakthrough pain: A managed care clinician’s guidebook. Driver LC, Jackson KC, Morrow T. Published by cme2 Woodcliff Lake, NJ. Publication May 2008.
PUBLISHED TEXTBOOK CHAPTERS (*denotes peer review)
1. *Lipman AG, Jackson KC. Nonprescription Antipyretics for Fever. Chapter for the 12th edition of the American Pharmaceutical Associations Handbook of Nonprescription Drugs. Publication: July 2000.
2. *Lipman AG, Jackson KC. Nonprescription Analgesics for Pain. Chapter for the 12th edition of the American Pharmaceutical Associations Handbook of Nonprescription Drugs. Publication: July 2000.
3. *Jackson KC, Lipman AG. Anxiety in Palliative Care Patients. In: Evidence-based Symptom Control in Palliative Care: Systematic Reviews and Validated Clinical Practice Guidelines for 15 Common Problems in Patients with Life-limiting Disease. Editors: Lipman AG, Jackson KC, Tyler LS. Haworth Press. Publication: September 2000.
4. *Jackson KC, Lipman AG. Delirium in Palliative Care Patients. In: Evidence-based Symptom Control in Palliative Care: Systematic Reviews and Validated Clinical Practice Guidelines for 15 Common Problems in Patients with Life-limiting Disease. Editors: Lipman AG, Jackson KC, Tyler LS. Haworth Press. Publication: September 2000.
5. *Martin AC, Jackson KC. Depression in Palliative Care Patients. In: Evidence-based Symptom Control in Palliative Care: Systematic Reviews and Validated Clinical Practice Guidelines for 15 Common Problems in Patients with Life-limiting Disease. Editors: Lipman AG, Jackson KC, Tyler LS. Haworth Press. Publication: September 2000.
6. *Jackson KC, Chambers MS. Oral Mucosal Problems in Palliative Care Patients. In: Evidence-based Symptom Control in Palliative Care: Systematic Reviews and Validated Clinical Practice Guidelines for 15 Common Problems in Patients with Life-limiting Disease. Editors: Lipman AG, Jackson KC, Tyler LS. Haworth Press. Publication: September 2000.
7. *Jackson KC. Nutrition and Hydration Problems in Palliative Care Patients. In: Evidence-based Symptom Control in Palliative Care: Systematic Reviews and Validated Clinical Practice Guidelines for 15 Common Problems in Patients with Life-limiting Disease. Editors: Lipman AG, Jackson KC, Tyler LS. Haworth Press. Publication: September 2000.
8. *Jackson KC, Lipman AG. Opioid Analgesics. Chapter in Clinical Management of Chronic Pain (Formerly Handbook of Chronic Pain Management). Editor C. David Tollison, Ph.D. Lippincott, Williams, and Wilkins. Published 12/2002.
9. *Lipman AG, Jackson KC. Opioids. Chapter in Principals and Practices of Pain Medicine. Editors Carol Warfield, M.D and Zahid Bajwa, M.D. December 2003.
10. *Jackson KC. Non-Steroidal Antiinflammatory Drugs and Adjuvant Analgesics. Chapter in Pain Management for Primary Care Clinicians. Editor Arthur G. Lipman. American Society of Health-System Pharmacists, July 2004.
11. *Jackson KC, Lipman AG. The Opioid Analgesics. Chapter in Pain Management for Primary Care Clinicians. Editor Arthur G. Lipman. American Society of Health-System Pharmacists, July 2004.
12. *Jackson KC. Opioid Pharmacokinetics. Opioids for Cancer Pain. Editors Mellar Davis, MD, et al. Oxford University Press, June 2005.
13. *Jackson KC, Smith HS. Overview of opioid-related terminology. Opioid Therapy in the 21st Century, Editors: Howard Smith, MD and Russell Portenoy, MD. Oxford University Press, February 2008.
14. *Smith HS, Jackson KC. Optimizing pharmacologic outcomes: Drug selection. Opioid Therapy in the 21st Century, Editor: Howard Smith, MD and Russell Portenoy, MD. Oxford University Press, February 2008.
15. *Jackson KC, Argoff CE. Skeletal Muscle Relaxants. Practical Management of Pain, 4th Ed. Editors Honorio Benzon, MD, et al. Mosby, March 2008.
16. *Jackson KC. Bowel Obstruction. Palliative Care Pocket Consultant. Editor: Phyllis Grauer, PharmD. Kendall/Hunt Publishing Company, September 2008.
17. *Jackson KC. Constipation. Palliative Care Pocket Consultant. Editor: Phyllis Grauer, PharmD. Kendall/Hunt Publishing Company, September 2008.
18. *Jackson KC. Dysphagia. Palliative Care Pocket Consultant. Editor: Phyllis Grauer, PharmD. Kendall/Hunt Publishing Company, September 2008.
19. *Jackson KC. Opioid Pharmacotherapy: Current Therapy in Pain. Editor: Howard Smith, MD. W.B. Saunders, Inc., January 2009.
20. *Jackson KC. Research in Palliative Care. ASHP Palliative Care and Pharmacy Textbook. Editor Jennifer Strickland, PharmD. ASHP Press, January 2009.
21. *Jackson KC. Pain Management. Boh’s Pharmacy Practice Manual, 3rd ed. Editor Susan M. Stein, MS, RPh. Lippincott, Williams and Wilkins, February 2009.
22. *Jackson KC, Davis M, Quigley C. Opioid Pharmacokinetics. Opioids for Cancer Pain, 2nd ed. Editors Mellar Davis, MD, et al. Oxford University Press, June 2009.
23. *Hardy JR, Jackson KC. Codeine. Opioids for Cancer Pain, 2nd ed. Editors Mellar Davis, MD, et al. Oxford University Press, June 2009.
24. *Davis M, Jackson KC. Equianalgesia. Opioids for Cancer Pain, 2nd ed. Editors Mellar Davis, MD, et al. Oxford University Press, June 2009.
25. *Jackson KC, Argoff CE. Chapter 76: Skeletal Muscle Relaxants and Analgesic Balms. Bonica’s Management of Pain, 4th ed. Editors Jane C. Ballantyne, MD, et al Lippincott, Williams and Wilkins, December 2009.
26. *Jackson KC, Smith HS. Overview of opioid-related terminology. Opioid Therapy in the 21st Century, 2nd Edition. Editors: Howard Smith, MD and Russell Portenoy, MD. Oxford University Press, January 2013.
27. *Jackson KC, Smith HS. Optimizing pharmacologic outcomes: Drug selection. Opioid Therapy in the 21st Century, 2nd Edition. Editors: Howard Smith, MD and Russell Portenoy, MD. Oxford University Press, January 2013.
28. *Neal DR, Jackson KC. Pain Management. Boh’s Pharmacy Practice Manual, 4th ed. Editor Susan M. Stein, DHEd, MS, RPh. Lippincott, Williams and Wilkins, April 2014.
OTHER PUBLICATIONS (*denotes peer review)
1. *Jackson KC, Lipman AG. Managing Pain in Osteoarthritis and Rheumatoid Arthritis. Continuing education monograph. Clinical Pharmacy Newswatch 6(2)1-8, July 1999.
2. *Jackson KC, Lipman AG. Safe and Effective Use of Opioids. PowerPak continuing education monograph. Published: Fall 1999.
3. *Jackson KC. Opioids Use in the Palliative Care Population. Continuing education monograph for the Philadelphia College of Pharmacy. Published: Fall 2000
4. Jackson KC. Pharmacology of Muscle Relaxants. Supplement to Emergency Medicine, April 2002: pg 5.
5. Jackson KC. Opioid tolerance revisited: Scientific basis and clinical significance. Congress Reporter 2002; 1(1):25-27.
6. Jackson KC. Novel Opioid analgesic strategies. Congress Reporter 2002; 1(1):30-32.
7. Jackson KC. Buprenorphine transdermal delivery system: Comparison with sublingual buprenorphine in Osteoarthritis pain. Congress Reporter 2002; 1(1): 42-44.
8. Jackson KC. The Pharmacology of Muscle Relaxants. Resident and Staff Physician 68(2): S5-S9, 2002.
9. *Jackson KC, Stanford BL. Opioid Use in Clinical Practice. CE Supplement to Pharmacy Times August 2003.
10. *Jackson KC. The Role of Cox-2 Selective NSAIDs in the Management of Chronic Pain. CE Supplement for CE City. September 2006.
11. *Fromer LM, Abramson SB, Jackson KC, Ryan L. Optimizing individualized management of osteoarthritis. US Pharmacist 2-hr CE.ACPE UAN: 430-000-09-012-H01-P; 430-000-09-012-H01-T. Published June 1, 2009.
12. * Arnstein PM, Fortier FR, Jackson KC. Clinicians’ guide to management of opioid therapy. Nurse Practitioner Healthcare Foundation and the American Academy of Physician Assistants. PRI Healthcare Solutions, New York. Published April 2010.
13. *Jackson KC, Ryan L. Navigating the management of chronic pain: a pharmacist’s guide. PowerPak 2-hr CE. ACPE UAN: 0430-0000-10-016-H01-P; 0430-0000-10-016-H01-T. Published May 10, 2010.
REVIEWS OF PUBLISHED WORKS
1. Jackson KC. Book Review – Palliative Care Formulary. Robert Twycross, Andrew Wilcock, and Sarah Thorp, Oxon, United Kingdom Radcliffe Medical Press, 1998. Journal of Pharmaceutical Care in Pain and Symptom Control 7(3), 89-92, 1999.
2. Jackson KC. Book Review – Pain Management: A Practical Guide for Clinicians, Fifth Edition. Richard S. Weiner, Ph.D., executive editor. Boca Raton, Florida. St. Lucie Press, 1998. Journal of Pharmaceutical Care in Pain and Symptom Control 7(1):91-2, 1999.
3. Jackson KC. CME Review – Low back pain: evaluation and conservative treatment. Elisabeth Lachmann and Willibald Nagler (presenters). Secaucus, New Jersey: Network for Continuing Medical Education, 1998, NCME, Program No. 727. Journal of Pharmaceutical Care in Pain and Symptom Control 7(1):93-5, 1999.
4. Jackson KC. , a new and emerging palliative care dot com. Journal of Pain and Palliative Care Pharmacotherapy 2002; 16(3):103-4.
5. Jackson KC. The Hopkins Opioid Program. Journal of Pain and Palliative Care Pharmacotherapy 2005; 19(3): 101-7.
6. Jackson KC. Better palliative care for older people. Journal of Pain and Palliative Care Pharmacotherapy 2005; 19(4):99-101.
7. Jackson KC. Pruritis in advanced disease. Journal of Pain and Palliative Care Pharmacotherapy 2006; 20(4):115-7.
8. Jackson KC. Pain Management at the End of Life: Bridging the Gap between Knowledge and Practice. Journal of Pain and Palliative Care Pharmacotherapy 2007; 21(4): 88.
9. Jackson KC. Hospice and Palliative Care Formulary USA. Journal of Pain and Palliative Care Pharmacotherapy 2009; 23(2)201-2.
10. Jackson KC. Pain Management for Older Adults: A self-help guide. Journal of Pain and Palliative care Pharmacotherapy 2008; 22(4): 350.
PUBLISHED MEDIA
1. TxPharm – Neurology: Nociceptive, Sympathetic, and Neuropathic Pain. Lectures 9, 10, 11. Copyright TTUHSC Healthnet July 2001
2. Chronic Pain Part 1: An Overview. Program Number 1112. Pharmacy, and Physical Therapy CE. Copyright TTUHSC Healthnet, Expires 3/31/2004
3. Chronic Pain Part 2: Opioid Analgesics. Program Number 7012. Pharmacy CE. Copyright TTUHSC Healthnet, Expires 3/31/2004.
4. Chronic Pain Part 3. Non-Opioid Pharmacotherapy. Program Number 1182. Pharmacy, and Physical Therapy CE. Copyright TTUHSC Healthnet, Expires 3/31/2004.
5. Pain Medications Part I. Program Number 30503. Nursing CE. Copyright TTUHSC Healthnet, Released 5/1/2003.
6. Pain in the Radiology Department. Program Number 10603. Radiologic Technologist CE. Copyright TTUHSC Healthnet, Released 5/1/2003.
7. Pain Medications Part II. Program Number 31603. Nursing CE. Copyright TTUHSC Healthnet, Released 6/1/2003.
8. You make the call: Case studies in breakthrough pain management. Pharmacist and physician 1-hr CE. Copyright cme2 Woodcliff Lake, NJ. ACPE #203-999-08-037-H01-P, 2008.
9. Argoff C, Bruckenthal P, Jackson K. Pain View III: Neuropathic pain and fibromyalgia syndrome. Nurse, pharmacist and physician 1-hr CE. Copyright Emerging Solutions in Pain/MediCom Worldwide, Morrisville, PA. ACPE # 827-0000-10-258-H01-P. Published August 13, 2010.
RESEARCH
2011 – 2012 Systematic Review of Pharmacotherapy for Delirium in Palliative Care. Co-Investigator.
2011 – 2012 Systematic Review of Pharmacotherapy for Anxiety in Palliative Care. Co-Investigator.
2009 – Systematic Review of Meperidine for Post-Operative Pain. Co-Investigator.
2009 – 2010 Appropriate Social Interaction Between Faculty and Pharmacy Students. Co-Investigator.
2008 – 2014 Systematic Review of Codeine for Management of Cancer Pain. Co-Investigator.
2006 – 2007 Analysis of Bupropion Pharmacotherapy and Counseling on Smoking Cessation in a Health Maintenance Organization: A Real World Analysis of Treatment Approaches and Results. Co-Principal Investigator.
2006 – 2007 Cost Benefit Analysis of Varenicline. Principal Investigator.
2005 – 2007 Compliance and Persistence with Combination Valsartan, Amlodipine, and HCTZ. Principal Investigator.
2005 – 2006 Compliance and Persistence with Combination Valsartan and HCTZ. Principal Investigator.
2003 – 2005 Pain Management to Medically Underserved Areas Using Telepharmacy. Principal Investigator.
2002 – 2005 Evaluation of Skeletal Muscle Relaxants in Ambulatory Care. Principal Investigator.
2001 – 2004 Health Literacy and OTC Pain Reliever Knowledge Among Seniors. Prinicipal Investigator – Cynthia Raehl, Pharm.D. Co-Principal Investigators – Kenneth C. Jackson, II, Pharm.D. and CAB Bond, Pharm.D.
2001 - 2004 Evidence-based Pharmacotherapy for Delirium in Palliative Care. Sponsored by The Cochrane Pain, Palliative Care and Supportive Care (PaPaS) Collaborative Review Group. Principal Investigator – Kenneth C. Jackson, II, Pharm.D.
2001 - 2004 Evidence-based Pharmacotherapy for Anxiety in Palliative Care. Sponsored by The Cochrane Pain, Palliative Care and Supportive Care (PaPaS) Collaborative Review Group. Principal Investigator – Kenneth C. Jackson, II, Pharm.D.; Co-Investigator – Arthur Lipman, Pharm.D.
2001- 2003 Pain Management Knowledge and Attitudes Amongst Hospice Nurses. Principal Investigator.
2000 - 2003 Analysis of Curricular Commitment to End of Life Care in United States Schools/Colleges of Pharmacy. Principal Investigator – Christopher Herndon, Pharm.D. Co-Principal Investigator – Kenneth C. Jackson, II, Pharm.D.
1998 – 2000 Field Validation of Evidence-Based Treatment Approaches for Symptom Control Problems in Dying Patients. Principal Investigator – Kenneth C. Jackson, II, Pharm.D.; Co-Investigator – Arthur G. Lipman, Pharm.D.; Study Coordinator – Kenneth C. Jackson, II, Pharm.D.
1999 – 2000 Open-label Dose-titration Study of Continuous Subcutaneous Infusion of Sufentanil Citrate for the Treatment of Chronic Pain. Principal Investigator – Arthur G. Lipman, Pharm.D.; Co-Investigators – Steve Lordon, M.D.; Kenneth C. Jackson, II, Pharm.D.; Edith C. Bautista, M.D.
1998 – 2000 Analysis of Physicians, Dentists, and Pharmacists Perceptions of Chronic Non-Malignant Pain. Principal Investigator – Paula Grahmann, Pharm.D.; Co-Investigators – Kenneth C. Jackson, II, Pharm.D. and Arthur G. Lipman, Pharm.D.
1998 – 1999 Study of the Prevalence and Treatment of Breakthrough Pain in Patients Using Transdermally Delivered Fentanyl for Management of Chronic Pain. Principal Investigator – Arthur G. Lipman, Pharm.D.; Co-Investigators – Michael Ashburn, M.D., M.P.H. and Kenneth C. Jackson, II, Pharm.D.,; Study Coordinator – Kenneth C. Jackson, II, Pharm.D.
1998 – 1999 Open-Label-Dose-Titration Study of E-Trans Fentanyl for the Treatment of Breakthrough Pain in Patients with Chronic Pain. Investigator – Arthur G. Lipman, Pharm.D.; Co-Investigators – Michael Ashburn, M.D., M.P.H. and Kenneth C. Jackson, II, Pharm.D.; Study Coordinator – Kenneth C. Jackson, II, Pharm.D.
GRANTSMANSHIP
2011 Analysis of the Viability of a MS Pharmacotherapy degree program. Pacific University Provost Incentive Grant Program $7,500. Investigator. Funded 2011.
2011 Development and Implementation of a University-based Pharmacotherapy Clinic. Pacific University Provost Incentive Grant Program $7,500. Investigator. Funded 2011.
2006 Analysis of Bupropion Pharmacotherapy and Counseling on Smoking Cessation in a Health Maintenance Organization: A Real World Analysis of Treatment Approaches and Results. Pfizer $263,000. Co-Principal Investigator. Funded 2006.
2006 Cost Benefit Analysis of Varenicline for Smoking Cessation, an Employers Perspective. Pfizer $75,000. Principal Investigator. Funded 2006.
2005 Compliance and Persistence Associated with the Use of Combination Varenicline and HCTZ, Comparison of Free Dose and Fixed Dose Combinations. Novartis $109,000. Funded 2005.
2005 Compliance and Persistence Associated with the Use of Combination Varenicline, Amlodipine and HCTZ for Patients Previously Naïve to Antihypertensive Pharmacotherapy. Novartis $109,000. Funded 2005.
2003 Evidence Based Systematic Review Training in Pain and Palliative Care. Pharmacia Corporation. $5,000. Investigator Initiated Grant. Principal Investigator. Funded 2003.
2003 Pain Management for Medically Underserved Communities Using Telepharmacy. The Merck Foundation. $30,151. Principal Investigator. Funded 2003.
2002 Evaluation of Skeletal Muscle Relaxant Use in Acute Pain and Musculoskeletal Injury in Ambulatory Settings. Elan Pharmaceuticals Investigator Initiated Grant. $42,941. Principal Investigator. Funded 2002.
2002 Evidence-based Pharmacotherapy for Depression in Geriatric Oncology Patients. Institute for Healthy Aging. $42,823. Principal Investigator. Not Funded. Invited to submit proposal for final round of funding.
2001 Health Literacy and Over the Counter (OTC) Pain Reliever Knowledge Among Seniors. United States Department of Health and Human Services Administration on Aging Grant. $75,000. Co-Principal Investigator. Funded 2001.
2001 Viability of Long-term Intrathecal Analgesia with Morphine Sulfate and Bupivacaine Hydrochloride Solutions Stored at Physiological Conditions. TTUHSC School of Pharmacy Seed Grant. $4,700. Principal Investigator. Funded 2001.
2001 Stability of High Dose Morphine Sulfate and Bupivacaine Hydrochloride in an Implantable Intrathecal Drug Delivery Device. Medtronic, Incorporated. $48,342. Principal Investigator. Submitted May 2001. (Not Funded)
2001 Evidence-Based Pharmacotherapy for Depression in Palliative Care. Astra-Zeneca Young Minds in CNS Award Program. $20,000. Principal Investigator. Submitted August 2001. (Not Funded)
NATIONAL & INTERNATIONAL PRESENTATIONS
1. American Pharmacists Association – San Diego, California. Annual Meeting – Satellite Symposium. Are you missing the signs? Opportunities for pharmacist interventions in the management of opioid-induced constipation. ACPE 0245-0000-15-002-L01-P. March 2015. (Moderator and Invited Speaker)
2. American Association of Colleges of Pharmacy – Seattle, Washington. Annual Meeting. The Role of Pain Pharmacotherapy in Pharmacy Education, A Roundtable Discussion. July 2010. (Invited Presentation)
3. American Society of Health Systems Pharmacy – Orlando, Florida. Mid-Year Clinical Meeting. The Role of the Pharmacist in Pain and Palliative Care. December 2008. (Invited Presentation)
4. Academy of Managed Care Pharmacy Annual Meeting – San Francisco, California. Opioid Pharmacotherapy: Abuse Deterrence the Next Frontier? April 2008. (Invited Presentation)
5. American Society of Health Systems Pharmacy – Las Vegas, Nevada. Mid-Year Clinical Meeting. Chronic Pain Pharmacotherapy: Clinical Pearls. December 2007. (Invited Presentation)
6. American College of Clinical Pharmacy – Memphis, Tennessee. Annual Meeting. What’s the Evidence for Chronic Low Back Pain Pharmacotherapy? October 2007. (Invited Presentation)
7. HospiScript Educational Conference – Dallas, Texas. Pain Pharmacotherapy and Care at the End of Life. July 2007. (Invited Presentation)
8. American Society of Health Systems Pharmacy – San Francisco, California. Annual Meeting. Pain Management and Palliative Care Learning Community. June 2007. (Invited Presentation)
9. American College of Clinical Pharmacy – Memphis, Tennessee. Spring Practice and Research Forum.
10. Assessing and Managing Pain: Addressing the Challenges. April 2007. (Invited Presentation)
11. American Society of Health Systems Pharmacy – Anaheim, California. Mid-Year Clinical Meeting. Pain Management and Palliative Care Pearls. December 2006. (Invited Presentation)
12. International Society of Pharmacoeconomic and Outcomes Research – Copenhagen, Denmark. Compliance and Persistence with Combination Pharmacotherapy for Hypertension. October 2006. (Invited Presentation)
13. HospiScript Lunch and Learn Teleconference Series. Oral Complications at the End of Life. August 2006. (Invited Presentation)
14. HospiScript Educational Conference – Des Moines, Iowa. Pain and End of Life Care. July 2006. (Invited Presentation)
15. American College of Clinical Pharmacy. Evidence Based Treatment for Pain Associated with Fibromyalgia. April 2006. (Invited Presentation)
16. HospiScript Educational Conference – Raleigh, North Carolina. Analgesic Considerations in Terminal Disease. November 2005. (Invited Presentation)
17. HospiScript Lunch and Learn Teleconference Series. Neuropathic Pain in the Palliative Care Setting. August 2005. (Invited Seminar)
18. American Pharmacists Association – Annual Meeting and Exposition. Getting to the Truth About Pain Management. March 2004. (Invited Presentation)
19. American Pharmacists Association – Annual Meeting and Exposition. Low Back Pain Pharmacotherapy. March 2004. (Invited Presentation)
20. American Society of Interventional Pain Physicians – Pain Specialization Board Review Course. General Principles of Pain Pharmacotherapy. September 2003. (Invited Presentation)
21. American Society of Interventional Pain Physicians – Pain Specialization Board Review Course. Adjuvant Pharmacotherapy in Pain Management. September 2003. (Invited Presentation)
22. American Society of Interventional Pain Physicians – Pain Specialization Board Review Course. Non-Opioid Pharmacotherapy. September 2003. (Invited Presentation)
23. American Academy of Nurse Practitioners – National Conference. Pain Pharmacology: Is it Really Just the Same Stuff on a Different Day. June 2003. (Invited Presentation)
24. Oncology Nurses Society – 28th Annual Congress. Current Pharmacological Options for Pain Management. May 2003. (Invited Presentation)
25. American Pharmaceutical Association – Annual Meeting and Exposition. Chronic Pain Management for Improved Quality of Life. April 2003. (Invited Presentation)
26. American Drug Utilization Review Society – Annual Symposium. Opioid Pharmacotherapy: An Evidence Base. February 2003. (Invited Presentation)
27. ASHP Midyear Clinical Meeting – Satellite Symposium. Contemporary Management of Pain: Analgesic Efficacy and Safety. December 2002. (Invited Presentation)
28. American Pharmaceutical Association’s Pain Management Academy. Hospice and Palliative Care: Issues in Pharmacy Education. November 2002. (Invited Presentation)
29. ASHP Advantage Dinner Meeting – San Antonio, Texas. Pain Management: Focus of Safety and Efficacy. October 2002. (Invited Presentation)
30. National Pain Management Advisory Board Meeting for Elan Pharmaceuticals. Skeletal Muscle Relaxants: Future Research. June 2002. (Invited Presentation)
31. National Pain Management Speaker Training Program for Elan Pharmaceuticals. Clinical Pharmacology of Skeletal Muscle Relaxants. June 2002. (Invited Presentation)
32. Orthopedic Pain Management Advisory Board Meeting for Elan Pharmaceuticals. Skeletal Muscle Relaxant Pharmacology. April 2002. (Invited Presentation)
33. American Society of Health-System Pharmacists Mid-Year Clinical Meeting – Symposium Organizer and Moderator: Managing Cancer Pain. December 2001. (Submitted Presentation)
34. American Society of Health-System Pharmacists Mid-Year Clinical Meeting – New Agents, Routes, and Approaches to Managing Cancer Pain. December 2001. (Submitted Presentation)
35. Academy of Managed Care Pharmacy Educational Conference - Emerging Trends and Guidelines in Pain Management for Managed Care. October 2001. (Invited Presentation)
36. American Academy of Pain Management, 12th Annual Clinical Meeting. Pain Pharmacotherapy with Anti-Inflammatory Agents. September 2001. (Invited Presentation)
37. Acute Care Management of Musculoskeletal Injury Meeting; Sponsored by Elan Pharmaceuticals. Pharmacotherapy of Skeletal Muscle Relaxants. September 2001. (Invited Presentation)
38. Acute Pain Management Advisory Board Meeting for Elan Pharmaceuticals. Pharmacological Considerations of Skeletal Muscle Relaxants. July 2001. (Invited Presentation)
39. The 12th National Meeting for State Cancer Pain Initiatives, American Alliance of Cancer Pain Initiatives. Pharmacotherapy for Neuropathic Pain. June 2001. (Invited Presentation)
40. American Pain Society 20th Annual Scientific Meeting. Unique Aspects of Methadone as an Analgesic Agent: Clinical Pharmacology. April, 2001. (Submitted Presentation)
41. Acute Pain Management Advisory Board Meeting for Elan Pharmaceuticals. Overview of the Pharmacology of Skeletal Muscle Relaxants. February 2001. (Invited Presentation)
42. American Society of Health-System Pharmacists Mid-Year Clinical Meeting: Satellite Symposia - Sustained-Release Analgesics for Nonmalignant Pain. December 2000. (Invited Presentation)
43. The 11th National Meeting for State Cancer Pain Initiatives, American Alliance of Cancer Pain Initiatives. Hot Topics in Pain Pharmacotherapy. June 2000. (Invited Presentation)
44. New England Cochrane Center (Pain, Palliative, and Supportive Care Collaborative Review Group) and TUFTS. Evidence-Based Symptom Control of Delirium in Palliative Care. June 2000. (Invited Presentation)
45. American Society of Health-System Pharmacists Mid-Year Clinical Meeting – Symposium Organizer and Moderator: Managing Chronic Non-Malignant Pain and Headaches with Opioids. December 1999. (Submitted Presentation)
46. American Society of Health-System Pharmacists Mid-Year Clinical Meeting – Chronic Non-Malignant Pain: Legal and Professional Issues. December 1999. (Submitted Presentation)
47. American Society of Health-System Pharmacists Mid-Year Clinical Meeting – Chronic Non-Malignant Pain: Introduction to a Complex Topic. December 1999. (Submitted Presentation)
48. American Academy of Hospice and Palliative Medicine (11th Annual Assembly)-Evidence-based, Drug Therapy Symptom Control Guidelines for Palliative Care. June 1999. Poster Presentation
49. American Academy of Hospice and Palliative Medicine (11th Annual Assembly) – The Development and Implementation of Evidence-Based Medicine in Palliative Care. June 1999. Plenary Session. (Submitted Presentation)
REGIONAL or STATE PRESENTATIONS
1. 13th Annual Southern West Virginia Hospice Educational Meeting. Pharmacotherapy for Delirium at the End of Life. June 2013. (Invited Presentation)
2. University of Charleston School of Pharmacy 3rd Annual Alumni Breakfast and Continuing Education Meeting. Pain 2013: Where are We? May 2013. (Invited Presentation)
3. University of Charleston School of Pharmacy, Rho Chi Chapter Initiation Keynote Address. October 2012. (Invited Presentation)
4. 18th Annual Northwest Federal Pharmacist Meeting. Chronic Pain and Opioids. June 2010. (Invited Presentation). ACPE 1-hr. 0071-9999-10-007-L01-P.
5. Oregon Pain Management Commission – Salem, Oregon. The Pacific University Pain Curriculum. April 2010. (Invited Presentation)
6. Oregon Society of Health-Systems Pharmacy Annual Meeting – Sunriver, Oregon. Neuropathic Pain Pharmacotherapy. April 2008. (Invited Presentation)
7. Oregon Society of Health-Systems Pharmacy Annual Meeting – Sunriver, Oregon. Chronic Low Back Pain: An analysis of the evidence. April 2008. (Invited Presentation)
8. University of Arizona College of Pharmacy Annual Winter CE Program – Park City, Utah. Chronic Pain and Outcomes: Dimensions in Suffering. December 2005. (Invited Presentation)
9. Utah Hospice and Palliative Care Organization. Interdisciplinary Competencies in End of Life Care. November 2005. (Invited Presentation)
10. Utah Society for Health-Systems Pharmacy. Fibromyalgia and Pain. October 2005. (Invited Presentation)
11. Dalton Pharmacy Association – Dalton, Georgia. Overview of Pharmacotherapy for Back Pain. June 2004. (Invited Presentation)
12. Lanier Pharmacy Association – Gainesville, Georgia. Low Back Pain: Focus on Muscle Relaxant Pharmacotherapy. April 2004. (Invited Presentation)
13. Texas Medical Association - Fifth Annual Eliminating Cancer Pain Symposium. Opioids and Substance Abuse: Presentation and Panel Discussion. February 2003. (Invited Presentation)
14. Mississippi Pain Society – Annual Meeting. Pain, Pills, and Politics. January 2003.(Invited Presentation)
15. Covenant Health System – Oncology Grand Rounds. Cancer Pain Management. July 2002. (Invited Presentation)
16. West Texas A & M University – Department of Sports and Exercise Sciences. Pain Pharmacotherapy with Anti-Inflammatory Agents. May 2002. (Invited Presentation)
17. Texas Society of Health-Systems Pharmacy – 54th Annual Seminar. Pain: The Past, Present, and Future. April 2002. (Invited Presentation)
18. American Cancer Society (Texas Division) – Annual Pain Management Symposium. Opioids and Substance Abuse. March 2002. (Invited Presentation)
19. Acute Pain Management Regional Advisory Board Meeting for Elan Pharmaceuticals. Clinical Pharmacology of Skeletal Muscle Relaxants (Las Vegas, NV). February 2002. (Invited Presentation)
20. Eastern New Mexico Family Practice Residency Program – Roswell, NM. Opioid Analgesics for the Family Practitioner. December 2001. (Invited Presentation)
21. Harris Methodist Hospital Ft. Worth, Texas – Annual Pain Management Seminar. The Pharmacology of Pain Management. November 2001. (Invited Presentation)
22. Northwest Texas Healthcare System – Pain Symposium (Amarillo, TX). Pharmacology of Acute and Chronic Pain. October 2001. (Invited Presentation)
23. Texas Tech University Health Sciences Center and Community Care Hospice (Odessa, TX). Pharmacotherapy for Neuropsychiatric Complications of Palliative Care. September 2001. (Invited Presentation)
24. Acute Pain Management Regional Advisory Board Meeting for Elan Pharmaceuticals (Baltimore, MD). Use of Skeletal Muscle Relaxants: From Pharmacology to Pharmacotherapy. August 2001. (Invited Presentation)
25. High Plains Emergency Nurses Association Annual Symposium. Pain Management for the Emergency Room Professional. July 2001. (Invited Presentation)
26. Acute Pain Management Regional Advisory Board Meeting for Elan Pharmaceuticals (Chicago, IL). Skeletal Muscle Relaxants: Pharmacology to Pharmacotherapy. July 2001. (Invited Presentation)
27. Acute Pain Management Regional Advisory Board Meeting for Elan Pharmaceuticals (Los Angeles, CA). Pharmacology and Pharmacotherapy of Skeletal Muscle Relaxants. June 2001. (Invited Presentation)
28. Texas Tech University Health Sciences Center, Department of Internal Medicine Weekly Report. Pain Management: A Primer. May 2001. (Invited Presentation)
29. Lubbock Christian University School of Nursing. Interdisciplinary Pain Management – The Pharmacist’s Perspective and Role. Presentation and Panel Discussion. May 2001. (Invited Presentation)
30. The Harrington Cancer Center and the Department of Veterans Affairs (Amarillo, TX). Pharmacotherapy for Neuropsychiatric Complications of Palliative Care. March 2001. (Invited Presentation)
31. West Texas Pharmacy Association Annual Meeting – Pain Management: An Overview. September 2000. (Invited Presentation)
32. St. Dominic – Jackson Memorial Hospital Cancer Conference – Management of Cancer Pain. October 1999. (Invitation Presentation)
33. The Utah Hospice Organization - Treatment of Nerve Injury Pain. April 1999. (Invited Presentation)
UNIVERSITY COMMITTEES
• Professional Pathways Program Subcommittee (Wingate 2014 – 2015)
• Practice Experience Advisory Committee (Wingate 2014 – 2015)
• Faculty Affairs Committee (Wingate 2013 – 2015)
o Elected by Peers
• Biomedical Informatics Advisory Committee (Wingate 2013 – 2014)
• University Registrar Search Committee (Pacific 2008 - 2009)
• College of Health Professions Personnel Committee (Pacific 2008-2011)
o Secretary 2009 – 2010
o Acting Chair 2011
• Scholarship Committee Chair – School of Pharmacy (Pacific 2009)
• Executive Committee – School of Pharmacy (Pacific 2011; South 2011-12; Charleston 2012- 2013)
• Dean’s Cabinet – School of Pharmacy (Pacific 2008-2011)
• School of Pharmacy Assessment Committee – School of Pharmacy (Pacific Ex Officio 2008 - 2011)
• Student Promotions Committee – School of Pharmacy (Pacific Ex Officio 2008 - 2011)
• Research Committee Chair – School of Pharmacy (Pacific 2008 - 2009)
• Faculty Search Committee – School of Pharmacy (Pacific 2007-8, Chair; Ex Officio 2008 - 2011)
• Research Committee (Pacific 2007 - 2008)
• Curriculum Committee (Pacific 2007 – 2008, Ex Officio 2008 – 2011; South 2011 – 2012)
• Seminar Committee (Utah 2006-7)
• Palliative Care Advisory Committee (Utah 2005-7)
• Pharmacy Practice Department Cabinet (Texas Tech 2003-4 Am Care Representative)
• Ambulatory Care Team Leader (Texas Tech 2003-4)
• Ambulatory Care Team Leader-Elect (Texas Tech 2002-3)
• School of Pharmacy Research Committee (Texas Tech Member and Chair-Elect 2003-4)
• School of Pharmacy Faculty Search Committee (Texas Tech Member Fall 2002-3)
• Health Sciences Library Committee: TTUHSC (Texas Tech Member: Spring 2001-3)
• Chair’s Advisory Roundtable and Exchange: Dept. of Pharmacy Practice TTUHSC (Member – Fall 2000, Spring 2001)
• TxPharm Curriculum Committee (Member – 4/2001 to 4/2003)
• Institutional Review Board (UMC/TTUHSC): (School of Pharmacy alternate member 2001-3)
PROFESSIONAL/ACADEMIC ACTIVITIES
• External Peer Reviewer – Promotion and Tenure
o Mercer University College of Pharmacy - 2014
o Harrison School of Pharmacy, Auburn University - 2014
o Pacific University School of Pharmacy – 2014
o South University School of Pharmacy - 2013
o Campbell University College of Pharmacy and Health Sciences - 2012
• Editor – The Pain, Palliative and Supportive Care Cochrane Review Group, the Cochrane Collaboration. 2007 - .
• American Society of Health-System Pharmacists – Member (14 years)
o Pain and Palliative Care Task Force Member 2006-8.
• American Pain Society – Member (12 years)
o American Pain Society Pharmacotherapy Special Interest Group – Co-Chair 2006-8.
o Continuing Education Advisory Committee – 2007.
o Educational Advisory Committee – 2008 to 2011.
o Ethics Committee – 2011 to 2012.
o Membership Committee – 2013 to present.
• International Association for the Study of Pain – Member (6 years)
• American Academy of Hospice and Palliative Medicine – Member (4 years)
• American Association of Colleges of Pharmacy – Member (4 years)
o Leadership Fellow 2009 – 2010
• American College of Clinical Pharmacy – Past Full Member (9 years)
o ACCP Pain Management Practice and Research Network – Newsletter Editor 2007-8, Chair Elect 2004-5, Chair 2005-6.
• Cochrane Pain, Palliative, and Supportive Care (PaPaS) Collaborative Review Group and Oxford Pain Relief Unit – Invited Visiting Researcher: August 2003 through October 2003.
• American Pain Society Fibromyalgia Clinical Practice Guideline Panel – selected as only pharmacist member to 10 person expert panel (2002-4)
• Expert Reviewer – Neck Pain Clinical Practice “PIER” Guidelines. The American College of Physicians - 2007
• WHO Normative Guidelines on Pain Management Delphi Panel – Expert External Consultant - 2007
• Catalan Agency for Health Technology Assessment and Research (Spain) – International Research Proposal Reviewer for Chronic Pain, 2007
• American Cancer Society Texas Division – Past Member (4 years)
o Board Member Cancer Pain Control Subcommittee (2001 - 5)
• Texas Higher Education Coordinating Board – Peer Reviewer for Nursing, Allied Health and other Health-Related Education Grant Program (2001)
• University of Houston College of Pharmacy Alumni Association – Former Member Board of Directors (3 years)
• American Pharmaceutical Association – Past Member (7 years)
• American Society of Parenteral and Enteral Nutrition – Past Member (5 years)
• American Academy of Pain Management – Past Member (3 years)
• International Association for Anesthesia Research – Past Member (2 years)
• Kappa Psi Pharmaceutical Fraternity – Regent (1 year), Sergeant-at-Arms (1year)
• Academy of Students of Pharmacy – President (2 years)
• Phi Lambda Sigma Pharmacy Leadership Society – Charter chapter initiate
SCHOLARSHIPS AND HONORS
• Pacific University - Promotion to Full Professor effective July 2011. (Unanimous approval)
• Academic Leadership Fellows Program – American Association of Colleges or Pharmacy, 2009 – 2010 Academic Year. (Competitive selection process)
• Pacific University – Granted indefinite tenure on May 13, 2010.
• Pacific University School of Pharmacy – P2 Teacher of the Year, Academic Year 2008 – 2009. (Based on student evaluation of instruction)
• Pacific University School of Pharmacy – Finalist P2 Teacher of the Year, Academic Year 2009 – 2010. (Based on student evaluation of instruction) Ineligible due to winning 2008 – 2009, received highest overall teaching evaluations both years.
• Pacific University School of Pharmacy – Finalist P2 Faculty Member of the Year, Academic Year 2008 – 2009.
• Pacific University School of Pharmacy - P2 Block of the Year Academic Year 2008 – 2009. Block Coordinator and Primary faculty member PHARM 618 Pain Pharmacotherapy. (Based on student evaluation of instruction)
• Texas Tech HSC School of Pharmacy – Nominated for P4 Preceptor of the Year. (2002, 2003, 2004)
• Harry M. Horvitz Palliative Care Center at the Cleveland Clinic - Roxane Visiting Scholar. (2000)
• American Pain Society Quality of Care Committee – Selected as a Clinical Pharmacy Consultant. (1998)
• University of Florida College of Pharmacy and ASTRA Pharmaceuticals – Preceptorship in Nutritional Support. (March 1998)
• Creighton University – Graduated Cum Laude. (1996)
• Creighton University – Dean’s List. (1996)
• University of Houston College of Pharmacy – Dean’s Award. (1989)
• Houston N.W. Medical Center Auxiliary – Academic Scholarship. (2 years)
• University of Houston – General Academic Scholarship. (5 years)
• National Dean’s List. (1985 and 1986)
• University of Houston – Dean’s List. (1985 and 1989)
ADVISORY BOARDS
2014 Zogenix Pharmaceuticals – Equianalgesia Advisory Board
2010 Acura Pharmaceuticals – Acurox FDA Advisory Board
2000 – 2004 ALZA Pharmaceuticals – Pain Management Advisory Board
2001 – 2004 ELAN Pharmaceuticals – Musculoskeletal Pain Advisory Board
2003 – 2005 Merck Pharmaceuticals – Musculoskeletal Pain Advisory Board
2005 – 2007 MedPointe Pharmaceuticals – Muscle Relaxant Advisory Board
MANUSCRIPT REVIEW/EDITORIAL CONSULTING
2013 – Present Founding Member Editorial Board – SOJ Anesthesia and Pain Management.
2013 – Present Founding Member Editorial Board – Austin Journal of Pharmacology and Therapeutics.
2007 – Present Editor: The Cochrane Pain, Palliative and Supportive Care Review Group.
2005 – 2008 Associate Editor: Journal of Pain and Palliative Care Pharmacotherapy.
2003 Pharmacy Today – The Role of Skeletal Muscle Relaxants in the Management of Acute Low Back Pain. CE Monograph Reviewer.
2001 – 2010 Journal of Pain and Palliative Care Pharmacotherapy – Editorial Board Member, Manuscript Reviewer.
2001 American Journal of Pain Management – Manuscript Reviewer.
2000 – 2001 Journal of Pharmaceutical Care in Pain and Symptom Control – Editorial Board Member.
2000 – 2011 Pain Practice – Editorial Board Member.
1998 – 2001 Journal of Pharmaceutical Care in Pain and Symptom Control – Manuscript Reviewer.
1998 Clinical Therapeutics – Editorial Consultant; October, 1998.
Last Updated February 2015
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- fidelity equity income ii fund
- jackson madison county school system jackson tn
- kenneth kunen set theory pdf
- arch pharm res impact factor
- pharm res journal
- arch pharm res
- jackson city school jackson ky
- kenneth kunen
- jackson radiology jackson ms
- jackson radiology jackson tn
- dr kenneth bell
- global pharm opioid calculator